# Probiotic (Visbiome) for Gulf War Illness

> **NCT03078530** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Ashok Tuteja** · enrollment: 60 (estimated)

## Conditions studied

- Gulf War Illness

## Interventions

- **DRUG:** Placebo
- **DRUG:** Visbiome
- **DRUG:** VSL#3

## Key facts

- **NCT ID:** NCT03078530
- **Lead sponsor:** Ashok Tuteja
- **Sponsor class:** FED
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-09-13
- **Primary completion:** 2018-05-31
- **Final completion:** 2018-05-31
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2017-12-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03078530

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03078530, "Probiotic (Visbiome) for Gulf War Illness". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT03078530. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*